Long-Term Liabilities: The sum of all non-current liabilities.
Ginkgo Bioworks Holdings, Inc. (DNA) had Long-Term Liabilities of $521.34M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$49.60M |
|
$-60.30M |
|
$14.82M |
|
$34.78M |
|
$115.14M |
|
$-65.54M |
|
$4.96M |
|
$-60.58M |
|
$-60.58M |
|
$-60.30M |
|
$-60.30M |
|
$-60.30M |
|
$-60.30M |
|
$-65.54M |
|
$-49.75M |
|
54.86M |
|
54.86M |
|
$-1.10 |
|
$-1.10 |
|
| Balance Sheet Financials | |
$523.02M |
|
$186.35M |
|
$707.98M |
|
$1.23B |
|
$96.72M |
|
-- |
|
|
Long-Term Liabilities |
$521.34M |
$618.06M |
|
$612.95M |
|
$546.80M |
|
$612.95M |
|
55.42M |
|
| Cash Flow Statement Financials | |
$-91.78M |
|
$-262.57M |
|
$-0.30M |
|
$605.74M |
|
$251.35M |
|
$-354.39M |
|
$42.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
70.12% |
|
-132.13% |
|
-132.13% |
|
-- |
|
-122.13% |
|
-121.56% |
|
$-99.44M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
2.14 |
|
41.96 |
|
-9.84% |
|
-11.03% |
|
-4.90% |
|
-9.84% |
|
$11.06 |
|
$-1.81 |
|
$-1.67 |
|